Vision Expo East 2024: Shedding light on orthokeratology with Dr Brianna Rhue
Dr Brianna Rhue, OD, FAAO, FSLS details her upcoming presentation "Cutting Out Surgery for the Management of Refractive Error," where she will detail the underutilization of orthokeratology during Vision Expo East 2024 later this week.
Vevye and the multifaceted world of treating dry eye
Marc R Bloomenstein, OD, FAAO, chats with Optometry Times on the benefits of using Vevye to treat dry eye disease, when to prescribe, and how to distinguish quality candidates.
Diagnose, treat, and prevent: What's to come at the 2024 IKA Keratoconus Symposium
Barry Eiden, OD, FAAO, FSLS, sits down with Optometry Times to highlight the importance of staying up-to-date with technology in the development of treatment and diagnosis of keratoconus and what's to come at this year's IKA Keratoconus Symposium in May.
Innovent Biologics meets primary endpoint for Phase 3 clinical trial, plans to submit NDA
February 28th 2024A treatment option for thyroid eye disease may be on its way to finalization in China with the positive endpoint results from a Phase 3 clinical trial of IBI311, a recombinant anti-insulin-like growth factor 1 receptor antibody.
Keep your eye on the ball: Chicago Bulls, White Sox team eye doctor weighs in on treating athletes
February 28th 2024R Tracy Williams, OD, FAAO, has been team optometrist for the Chicago Bulls and White Sox for over 20 years. He details how treatment of professional athletes is different than the general public in an exclusive interview with Optometry Times.
Alcon announces MARLO updates with anticipated unveiling of new app at SECO 2024
February 27th 2024The eye care device company has announced that MARLO has gone mobile with a new app, which allows patients to order contact lenses, perform vision screening, and access eye disease and care information.